Gender differences in the brain: Are they relevant to the pathogenesis of schizophrenia?

Comprehensive Psychiatry

Volumn 30, Issue 3, 1989, Pages 197-208

  Delisi, Lynn E ^a,b   Dauphinais, I Deborah ^a,b   Hauser, Peter ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; GENDER; HUMAN; SCHIZOPHRENIA; SHORT SURVEY; THEORETICAL STUDY;

BRAIN; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; HUMAN; NEUROTRANSMITTERS; SCHIZOPHRENIA; SEX CHARACTERISTICS; SEX HORMONES;

EID: 0024560827     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-440X(89)90038-2     Document Type: Article

References (111)

1. Historical perspectives to the dopamine hypothesis of schizophrenia
2. The Neurochemical Aspects of Schizophrenia
3. Schizophrenia: An amotivational syndrome in men
4. Gender differences in schizophrenia
5. Offspring of schizophrenics III
6. Schizoid personality in childhood A controlled follow-up study
7. Patterns of childhood and social development in adult schizophrenia
8. Sex and schizophrenia
9. A study of “atypical schizophrenia”: Comparison with schizophrenia and affective disorder by sex, age of admission, precipitant, outcome, and family history
10. Sex differences in age at first hospital admission for schizophrenia: A fact or artifact?
11. Sex differences in schizophrenia
12. Sex differences and the schizophrenic experience
13. Sex difference in age of onset of schizophrenia
14. Early manifestations and first-contact incidence of schizophrenia in different cultures
15. Cross-cultural differences in the short-term prognosis of schizophrenic psychoses
16. Prognostic implications of the sex of schizophrenic patients
17. Drugs and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients
18. Interaction of sex, age, and neuroleptic dose
19. Dopamine inhibition of action potentials in a prolactin secreting cell line is modulated by estrogens
20. Schizophrenia: Sex differences
21. Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression, and surgical conditions
22. A follow-up and family study of schizophrenia
23. The genetics of schizophrenia: A reassessment using modern criteria
24. Familial relatedness of schizophrenia and schizotypal states
25. Familial concordance by sex with respect to schizophrenia
26. The etiology of so-called schizophrenic psychosis
27. The genetic theory of schizophrenia: An analysis of 691 schizophrenic twin index families
28. The Huxley lecture on hereditary aspects of nervous and mental disease
29. Survey of cases of familial mental illness
30. A study of pairs of sibs both hospitalized for mental disorder
31. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder
32. Genetic marker studies in schizophrenia
33. Toomey: Psychiatric disability associated with the fragile X chromosome
34. Clinical and experimental observations on catatonia
35. A correlative study of endocrine imbalances and mental disease
36. Normal and morbid conditions of the testes from birth to old age in one hundred asylum and hospital cases
37. The pathological anatomy of the ductless glands in a series of dementia praecox cases
38. Morphology of the testes in schizophrenia
39. The biological investigation of schizophrenia
40. Cytogenetic studies in schizophrenic patients
41. Cytogenetic studies of males with schizophrenia: Screening for the fragile X chromosome and other chromosomal abnormalities
42. Distribution of androgeny in men patients
43. Uber die eirstocksfunktion bei dementia praecox auf grund anatomischer untersuchungen
44. Adrenocortical activity in relation to the severity of schizophrenia
45. Plasma androgens in male schizophrenics
46. Steroid metabolism in schizophrenia, depression, and mania
47. Androgen metabolism in schizophrenics, homosexuals, and normal controls
48. Sex hormone relationships in schizophrenic men
49. Psychosexuality on schizophrenia—some endocrine considerations
50. Serum gonadotrophin and testis biopsy in the treatment of schizophrenia
51. Use of dehydroisoandrosterone in psychiatric treatment
52. Periodic psychosis recurring in association with menstrual cycle
53. Postpartum disorders
54. Anterior pituitary hormone secretion in chronic schizophrenia: An approach to neurohumoral mechanisms
55. Anterior pituitary hormone secretion in chronic schizophrenics
56. Gonadotropin response to gonadotropin hormone-releasing hormone (GnRH) in acute schizophrenia
57. Gonadotropin response to synthetic gonadotropin hormone-releasing hormone (GnRH) in chronic schizophrenia
58. On the genesis of sexual differentiation of the central nervous system: Morphogenetic consequences of steroidal exposure and possible role of alpha-fetoprotein
59. Gonadal hormones and brain development: Implications for the genesis of sexual differentiation
60. Sexual differentiation of the central nervous system
61. Gonadal steroid influences on brain development and sexual differentiation
62. Morphologic changes in the brains of adult male rats after neonatal castration
63. Structural changes in the hypothalamic ventromedial nucleus of the male rat following neonatal castration and androgen treatment
64. Sexual dimorphism in the neurophil of the preoptic area of the rat and its dependence on neonatal androgen
65. Sexual differentiation of the forebrain: Relationship to gonadotropin secretion
66. Hemispheric asymmetries in the behavioral and hormonal effects of sexually differentiating mammalian brain
67. Participation of estrogens in female sexual differentiation of the brain: Neuroanatomical, neuroendocrine, and behavioral evidence
68. Nuclear and cytosolic androgen receptor levels in the limbic brain of neonatal male and female rats
69. Atlas of estradiol concentrating cells in the central nervous system of the female rat
70. Differentiation of the sexually dimorphic nucleus in the preoptic area of the rat brain is determined by the perinatal hormone environment
71. Independent control of sexual and scent marking behavior of male gerbils by cells in or near the medial preoptic area
72. Organizational action of estrogen on synaptic pattern in the amygdala: Implications for sexual differentiation of the brain
73. A sexually dimorphic nucleus in the human brain
74. Sexual dimorphism in the human corpus callosum
75. The brain connection: The corpus callosum is larger in left-handers
76. Can the corpus callosum predict gender, age, handedness, or cognitive differences?
77. Sex differences in brain organization for verbal and non-verbal functions
78. Sex differences in human brain asymmetry A critical survey
79. Sex differences in human cerebral function
80. Handedness and sex differences in hemispheric asymmetry
81. Left handedness: Association with immune disease, migraine, and developmental learing disorder
82. Gyral development of the human brain
83. Hemispheric lateralization and schizophrenia
84. Basal genglia and limbic system pathology in schizophrenia
85. A morphometric study of the dopamine containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
86. Postmortem evidence of structural brain changes in schizophrenia: Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder
87. A neurohistological correlate of schizophrenia
88. Disorientation of the hippocampal pyramidal cell and its processes in the schizophrenic patient
89. A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia
90. Corpus callosum thickness in schizophrenia
91. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia
92. Lack of clinical correlates to hypofrontality on PET in schizophrenia
93. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia
94. Increased dopamine receptor sensitivity in schizophrenia
95. Dopamine receptors and schizophrenia: Drug effect or illness?
96. Bimodal distribution of dopamine receptor densities in brains of schizophrenics
97. Dopamine D-2 receptors in schizophrenia studied in vivo
98. Positron emission tomography reveals elevated D-2 dopamine receptors in drug-naive schizophrenics
99. Down-regulation by 17-beta-estradiol of D-2 dopamine receptors in the MtTF-4 pituitary tumor
100. In vivo effects of estrogen and 2-hydroxyestradiol on D-2 dopamine receptor agonist affinity states in rat striatum
101. Effect of estradiol and haloperidol in hypophysectomized rat brain dopamine receptors
102. Analysis of temporal and dose-dependent effects of estrogen on monamines in brain nuclei
103. Monoamine levels and turnover in brain: Relationship to priming actions of estrogen
104. Dopamine-B-hydroxylase inhibitor modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland
105. A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin has different effects on prolactin secretion in male and female rats
106. Rat brain serotonin Biochemical and functional evidence for a sex difference
107. Serotonergic influences on sexual differentiation of the rat brain